Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PRECISION BIOSCIENCES INCDTIL · Entity 6284 | CEO of Elo Life Systems | June 07, 2021 | June 09, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PRECISION BIOSCIENCES INC
Report date June 07, 2021 · Filed June 09, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.34 · Expires 2031-06-06 | Direct | 41,240 |
Reported balance
After 2021-06-07 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-06-07 · Grant · Acquired 41,240 · Balance 41,240 F1: The option vests as to 25% of the underlying shares on June 7, 2022 and thereafter in twelve equal installments at the end of each three-month period over the 36 months following such date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 23,999 |
Reported balance
After 2021-06-07 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-06-07 · Grant · Acquired 23,999 · Balance 23,999 F2: The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of the Company's Common Stock. F3: The RSUs shall vest in three substantially equal annual installments on the anniversary of the grant date of such RSUs, subject to the Reporting Person's continued service to the Company through the applicable vesting dates. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests as to 25% of the underlying shares on June 7, 2022 and thereafter in twelve equal installments at the end of each three-month period over the 36 months following such date.
F2: The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of the Company's Common Stock.
F3: The RSUs shall vest in three substantially equal annual installments on the anniversary of the grant date of such RSUs, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 07, 2021 Filed Jun 9, 2021 22:39 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | GrantRestricted Stock Units · Derivative | 23,999 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-039281 · doc4.xml · derivative · entry 2 KHAZI FAYAZ · CIK 0001770314 · CEO of Elo Life Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,999 Underlying: Common Stock · 23,999 shares Expires not disclosed F2 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of the Company's Common Stock. F3 · derivative.exercise_date: The RSUs shall vest in three substantially equal annual installments on the anniversary of the grant date of such RSUs, subject to the Reporting Person's continued service to the Company through the applicable vesting dates. F3 · derivative.expiration_date: The RSUs shall vest in three substantially equal annual installments on the anniversary of the grant date of such RSUs, subject to the Reporting Person's continued service to the Company through the applicable vesting dates. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 22:39 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | GrantEmployee Stock Option (Right to Buy) · Derivative | 41,240 | $0.00 Strike: $11.34 | $0.00 |
DisclosureSEC source: 0001209191-21-039281 · doc4.xml · derivative · entry 1 KHAZI FAYAZ · CIK 0001770314 · CEO of Elo Life Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,240 Underlying: Common Stock · 41,240 shares Expires 2031-06-06 F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares on June 7, 2022 and thereafter in twelve equal installments at the end of each three-month period over the 36 months following such date. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 21:00 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | GrantEmployee Stock Option (Right to Buy) · Derivative | 107,391 | $0.00 Strike: $8.21 | $0.00 |
DisclosureSEC source: 0001209191-20-035586 · doc4.xml · derivative · entry 1 KHAZI FAYAZ · CIK 0001770314 · CEO of Elo Life Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,391 Underlying: Common Stock · 107,391 shares Expires 2030-06-07 F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares on April 1, 2021 and vests in equal installments at the end of each successive three-month period over the 36 months following such date. Read SEC document |
| September 23, 2019 Filed Sep 25, 2019 20:27 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | GrantEmployee Stock Option (Right to Buy) · Derivative | 28,833 | $0.00 Strike: $9.46 | $0.00 |
DisclosureSEC source: 0001209191-19-050706 · doc4.xml · derivative · entry 1 KHAZI FAYAZ · CIK 0001770314 · CEO of Elo Life Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,833 Underlying: Common Stock · 28,833 shares Expires 2029-09-22 F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares on April 1, 2020 and vests in equal installments at the end of each successive three-month period over the 36 months following such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.